Massively parallel single cell analysis
US-9567646-B2 · Feb 14, 2017 · US
US11873483B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11873483-B2 |
| Application number | US-201615557442-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 11, 2016 |
| Priority date | Mar 11, 2015 |
| Publication date | Jan 16, 2024 |
| Grant date | Jan 16, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The disclosure provides methods and compositions useful for labeling of target molecules with origin-specific nucleic acid identifiers (for example, barcodes), which can be used subsequently to identify, quantify, or otherwise characterize a feature or activity of target molecules originating from a particular discreet volume. Such target molecules can include polypeptides expressed by cells, in which nucleic acid molecules encoding the polypeptides are labeled with the same, or matched, origin-specific nucleic acid identifiers.
Opening claim text (preview).
We claim: 1. A method of identifying whether a target mRNA and a target polypeptide in individual compartments are from the same compartment, comprising: generating subsamples by segregating a sample, or a portion thereof, into individual compartments, the sample comprising a cell, a population of cells, or an acellular system, wherein each of the individual compartments further comprise: a first oligonucleotide comprising an origin specific barcode sequence, a unique molecular identifier sequence unique to a target mRNA from the subsamples, and a sequence for binding the target mRNA; a second oligonucleotide comprising an origin specific barcode sequence and a unique molecular identifier sequence unique to a target polypeptide from the subsamples, and a molecule for capturing the target polypeptide; and wherein the origin specific barcode sequence of the first oligonucleotide and the origin specific barcode sequence of the second oligonucleotide are the same in each of the individual compartments but differ among the individual compartments; labeling the target mRNA and the target polypeptide in each of the individual compartments by binding of the first oligonucleotide to the target mRNA and binding of the second oligonucleotide to the target polypeptide, wherein the target mRNA and the target polypeptide in each of the individual compartments are from the acellular system of the subsample or a lysed cell or lysed population of cells of the subsamples within the individual compartments prior to the labeling step; generating a cDNA product in each of the individual compartments from all or a portion of the labeled target mRNA by introducing reagents for generating the cDNA product into each of the individual compartments such that the origin specific barcode sequence of the first oligonucleotide and the unique molecular identifier sequence unique to the target mRNA is incorporated into the cDNA product; producing pooled cDNAs by pooling the cDNA product from each of the individual compartments and generating different amplicons comprising the origin specific barcode sequence of the first oligonucleotide and the unique molecular identifier sequence unique to the target mRNA by amplifying the pooled cDNAs, wherein the origin specific barcode sequence of the first oligonucleotide in each of the different amplicons is different; isolating the labeled target polypeptide labeled in the labeling step from each of the individual compartments and obtaining different cleaved products comprising the origin specific barcode sequence of the second oligonucleotide and the unique molecular identifier sequence unique to the target polypeptide by cleaving the labeled target polypeptide from each of the individual compartments; and identifying whether a target mRNA and a target polypeptide in the individual compartments are from the same compartment by sequencing of the origin specific barcode sequence of the first oligonucleotide and unique molecular identifier sequence unique to the target mRNA in each of different amplified products and sequencing the origin specific barcode of the second oligonucleotide and unique molecular identifier sequence unique to the target polypeptide in each of the different cleaved products, wherein the origin specific barcode sequence of the first oligonucleotide associated with the target mRNA and the origin specific barcode sequence of the second oligonucleotide associated with target polypeptide are identical indicates that the target mRNA and the target polypeptide in the individual compartments are from the same compartment. 2. The method of claim 1 , wherein each of the individual compartments comprises a single cell from the sample. 3. The method of claim 1 , wherein the target polypeptide is expressed on the surface of the cell or the population of cells. 4. The method of claim 1 , wherein the first oligonucleotide and the second oligonucleotide further comprise one or more primer sequences, a sequencing adaptor, one or more restriction sites, or a capture moiety. 5. The method of claim 4 , wherein the primer sequences are universal primer sequences, and/or wherein the origin specific barcode sequence of the first oligonucleotide or the second oligonucleotide comprises RNA, DNA, or a combination of RNA and DNA. 6. The method of claim 1 , wherein the first oligonucleotide and the second oligonucleotide are reversibly or irreversibly attached to a solid substrate in each of the individual compartments. 7. The method of claim 6 , wherein each of the first oligonucleotide and the second oligonucleotide is attached to the solid substrate by an adapter binding sequence located on each of the first oligonucleotide and second oligonucleotide that binds to an adapter nucleotide sequence on the solid substrate. 8. The method of claim 6 , wherein the solid substrate is a hydrogel bead. 9. The method of claim 6 , wherein the first oligonucleotide and the second oligonucleotide are released from the solid substrate prior to the labeling step. 10. The method of claim 9 , wherein the first oligonucleotide and the second oligonucleotide are released from the solid substrate by breaking down of the solid substrate, or by chemical cleavage, photocleavage, or enzymatic cleavage of the first oligonucleotide and the second oligonucleotide. 11. The method of claim 1 , wherein the molecule for capturing the target polypeptide comprises a small molecule, an antigen, an antibody, a protein binding domain, a nucleic acid, or a polysaccharide. 12. The method of claim 11 , wherein the target polypeptide is a target polypeptide having a post-translational modification and the molecule for capturing the target polypeptide is an antibody specifically binding to the target polypeptide having the post-translational modification. 13. The method of claim 1 , wherein the molecule for capturing the target polypeptide is an antibody specifically binding to the target polypeptide. 14. The method of claim 1 , wherein the target polypeptides is located on a surface of the cell or one or more cells of the cell population, and the molecule for capturing the target polypeptide is a binding partner of the target polypeptide, or wherein the target polypeptide is an antibody expressed by the cell or one or more cells of the population of cells and the molecule for capturing the target polypeptide is an antigen of the antibody, or wherein the target polypeptide is a cell surface receptor and the target mRNA is a mRNA encoding the cell surface receptor. 15. The method of claim 1 , wherein the target mRNA encodes an antibody light chain, an antibody heavy chain, or a complementarity determining region (CDR). 16. The method of claim 15 , wherein the cell is a B cell, a T cell, a plasmablast or a plasma cell. 17. The method of claim 1 , wherein the molecule for capturing the target polypeptide is not attached directly to the second oligonucleotide and comprises an oligonucleotide tag, and wherein the second oligonucleotide further comprises a sequence capable of hybridizing to the oligonucleotide tag. 18. The method of claim 17 , wherein the molecule for capturing the target polypeptide is bound to a first member of a binding pair and the oligonucleotide tag is bound to a second member of the binding pair. 19. The method of claim 18 , wherein the binding pair is streptavidin-biotin pair. 20. The method of claim 17 , wherein the molecule for capturing the target polypeptide and the oligonucleotide tag are biotinylated and bound to a linking streptavidin
by coupling phenotype to genotype, not provided for in other groups of this subclass · CPC title
characterised by the detection means (C12Q1/6804 takes precedence) · CPC title
Methods of identifying protein-protein interactions in protein mixtures · CPC title
Oligonucleotides as tagging agents for labelling antibodies · CPC title
Microreactors, e.g. emulsion PCR or sequencing, droplet PCR, microcapsules, i.e. non-liquid containers with a range of different permeability's for different reaction components · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.